Skip to main content

Want a detailed portfolio tracker?

Upstream Bio (UPB) P/E (2024 - 2026)

Upstream Bio (UPB) P/E from Dec 31, 2024 to Jul 21, 2026. The TTM Upstream Bio (UPB) P/E is -2.41. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Upstream Bio (UPB)

YearP/EChange
2026-2.41-76.40%
2025-10.21-75.39%
2024-41.49N/A

Comparison Upstream Bio (UPB) P/E with competitors

Upstream Bio (UPB) P/E is -2.41.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.00-100.18%
ENLVEnlivex Ltd0.07-103.10%
FGENFibroGen Inc0.24-109.96%
CHRSCoherus Biosciences Inc0.85-135.21%
FBIOFortress Biotech Inc0.95-139.38%
ORMPOramed Pharmaceuticals Inc1.50-162.37%
AGENAgenus Inc3.01-224.89%
INVAInnoviva Inc3.15-230.89%
VXRTVaxart Inc3.55-247.31%
CRMDCorMedix Inc3.63-250.57%
CVACCureVac N.V.4.45-284.49%
GLPGGalapagos NV4.86-301.63%
SRPTSarepta Therapeutics Inc4.88-302.60%
ABEOAbeona Therapeutics Inc5.39-323.57%
ABUSArbutus Biopharma Corp5.60-332.21%
ZVRAZevra Therapeutics Inc5.89-344.31%
SPROSpero Therapeutics Inc6.23-358.47%
CGENCompugen Ltd6.31-362.02%
RIGLRigel Pharmaceuticals6.87-385.18%
SLXNSilexion Therapeutics Corp7.30-402.77%
OMEROmeros Corporation9.26-484.22%
AUPHAurinia Pharmaceuticals Inc9.58-497.76%
PLXProtalix BioTherapeutics Inc10.89-551.96%
ACADAcadia Pharmaceuticals Inc11.73-586.71%
TBPHTheravance Biopharma Inc12.26-608.86%
ADMAAdma Biologics Inc12.42-615.33%
HRMYHarmony Biosciences Holdings Inc13.82-673.51%
SABSSAB Biotherapeutics Inc14.14-686.63%
NAGENiagen Bioscience Inc14.82-714.93%
INCYIncyte Corp15.82-756.61%
REGNRegeneron Pharmaceuticals Inc15.86-758.02%
PBYIPuma Biotechnology Inc17.32-818.57%
CPRXCatalyst Pharmaceuticals Inc17.44-823.70%
EXELExelixis Inc17.54-827.80%
TGTXTG Therapeutics Inc18.97-887.06%
MDXGMimedx Group Inc20.55-952.89%
XOMAXOMA Royalty Corp22.87-1049.29%
ARGXArgen X SE24.30-1108.35%
CTMXCytomX Therapeutics Inc24.82-1130.06%
XOMAOXOMA Royalty Corp25.34-1151.79%
HALOHalozyme Therapeutics Inc25.62-1163.37%
XOMAPXOMA Royalty Corp25.67-1165.29%
VRTXVertex Pharmaceuticals Inc27.99-1261.76%
RPRXRoyalty Pharma plc - Class A28.69-1290.52%
SLNOSoleno Therapeutics Inc29.02-1304.12%
ASNDAscendis Pharma A/S30.09-1348.53%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1673.33%
APLSApellis Pharmaceuticals Inc39.02-1719.36%
BMRNBiomarin Pharmaceutical Inc42.21-1851.77%
KRYSKrystal Biotech Inc45.34-1981.73%
ONCBeiGene Ltd69.54-2985.89%
PHARPharming Group N.V.75.03-3213.52%
TECHBio-Techne Corp101.96-4331.22%
VCELVericel Corp109.92-4661.67%
ALNYAlnylam Pharmaceuticals Inc117.96-4995.49%
GMABGenmab140.29-5921.99%
TLXTelix Pharmaceuticals Ltd162.15-6829.25%
CORTCorcept Therapeutics Inc212.86-8933.47%